SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, John D. Sheppard, MD, MMSc, discusses the use of Vevye from Harrow to treat dry eye disease.
Vevye, a 0.1% cyclosporine ophthalmic solution, is the first cyclosporine-containing product to receive FDA approval for treating signs and symptoms of DED, as well as the first to demonstrate a minimal side effect profile, Sheppard said.
“You, as the prescriber, will find a successful level of enthusiasm, results, side effect reduction and sign and symptom improvement for your dry eye patients,” (Read more...)